Direxion Daily S&P Biotech Bull 3x Shares (LABU) Holdings $61.64 +2.24 (+3.77%) Closing price 04:10 PM EasternExtended Trading$61.75 +0.11 (+0.18%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Top 50 LABU HoldingsRankCompanyCurrent PriceWeightShares Held1Dreyfus Govt Cash Man InsN/A29.79%161,073,6972Goldman Sachs Sterling FixInc Port IncN/A25.03%135,337,3353Dreyfus Trsry Securities Cash MgmtN/A8.08%43,706,1434NTRANatera$157.01+3.7%1.86%67,9295VRTXVertex Pharmaceuticals$498.660.0%1.79%19,8066INSMInsmed$72.640.0%1.78%132,5597ALNYAlnylam Pharmaceuticals$259.01+1.5%1.76%40,4738NBIXNeurocrine Biosciences$109.48+2.7%1.69%89,9819UTHRUnited Therapeutics$295.73+0.6%1.68%31,95410GILDGilead Sciences$102.62-0.6%1.66%86,103 Get the Latest News and Ratings for LABU and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and its competitors with MarketBeat's FREE daily newsletter. 11EXASExact Sciences$52.51+11.3%1.63%211,75212AMGNAmgen$278.30-1.9%1.61%31,40713INCYIncyte$61.97-0.1%1.56%144,90414BIIBBiogen$122.52+1.3%1.54%70,00015MDGLMadrigal Pharmaceuticals$318.41-2.8%1.52%27,16016ABBVAbbVie$197.00+1.9%1.48%46,28017REGNRegeneron Pharmaceuticals$609.45+3.3%1.48%14,22718BPMCBlueprint Medicines$102.07+2.8%1.41%90,19019EXELExelixis$39.10+0.5%1.40%209,01420Goldman Sachs Fin Gov 465 InstitutN/A1.32%7,141,15021BMRNBioMarin Pharmaceutical$61.13-2.5%1.30%118,91322MRNAModerna$27.76+2.7%1.28%280,34123TGTXTG Therapeutics$44.80-1.2%1.17%165,14124BBIOBridgeBio Pharma$38.51+0.3%1.15%183,54025HALOHalozyme Therapeutics$61.11+1.8%1.10%100,89526RVMDRevolution Medicines$41.13+1.2%1.01%148,39527CYTKCytokinetics$36.62-14.7%0.98%133,91628SMMTSummit Therapeutics$28.72+16.4%0.95%208,61329CRSPCRISPR Therapeutics$39.26+4.1%0.93%132,60430SRPTSarepta Therapeutics$63.48+1.1%0.88%88,50231IONSIonis Pharmaceuticals$32.76+3.3%0.84%160,04032ROIVRoivant Sciences$11.61+0.2%0.84%450,14033ADMAADMA Biologics$23.57+1.3%0.80%202,80134VKTXViking Therapeutics$29.29+2.3%0.74%166,87935SWTXSpringWorks Therapeutics$46.22+0.0%0.71%100,73536S&P Biotechnology Select Industry Index SwapN/A0.70%36,20637ALKSAlkermes$31.34+2.5%0.68%136,61238KRYSKrystal Biotech$167.69+1.2%0.68%21,95039PCVXVaxcyte$36.53+3.7%0.68%119,68440RNAAvidity Biosciences$32.28-1.2%0.65%131,509Gold Alert: The Truth About Fort Knox Is Coming (Ad)Owning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s already performing nearly twice as well as gold this year and looks ready to go much higher. If you wait for the news to hit, you’ll already be too late.Click here now before the biggest gold run in decades kicks off.41NUVLNuvalent$78.30+2.7%0.62%46,48342ACLXArcellx$65.77+0.4%0.61%53,12243TWSTTwist Bioscience$40.35+7.0%0.61%90,14844RYTMRhythm Pharmaceuticals$65.12+2.1%0.60%52,41945SRRKScholar Rock$32.35-1.3%0.58%101,40746VCYTVeracyte$30.41+2.3%0.58%100,75747APLSApellis Pharmaceuticals$20.53+2.2%0.55%163,57748RXRXRecursion Pharmaceuticals$5.81+5.5%0.55%543,39849SLNOSoleno Therapeutics$74.990.0%0.54%42,09150RAREUltragenyx Pharmaceutical$39.55+1.5%0.53%80,642 Geographic ExposureUnited States60.9%Bermuda0.9%Switzerland0.8%Ireland0.8%Virgin Islands, British0.4%Currency ExposureUSD351.5%Sector ExposureHealth Care63.0%Consumer Discretionary0.7%Biotechnology0.3%Industry ExposureBiotechnology58.7%Health Care Equipment & Supplies2.9%Health Care Providers & Services1.7%Distributors0.6%Diversified Consumer Services0.1%SubIndustry ExposureBiotechnology58.7%Life Sciences Tools & Services2.6%Health Care Services1.7%Pharmaceuticals0.5%Health Care Equipment0.2%Health Care Supplies0.1%Coupon Exposure4-652.6%Maturity Exposure20-30235.4% Related Companies and Tools Related Companies IHE Holdings PPH Holdings IHF Holdings RSPH Holdings BBH Holdings FXH Holdings PJP Holdings PBE Holdings RYH Holdings XHE Holdings This page (NYSEARCA:LABU) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
